drugset / Trial / NCT03239119
The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
RandomizedParallel-groupDouble-blindTreatment
Summary
This research is a randomized, double-blind,controlled trial. 456 Chinese subjects with Type 2 Diabetes Mellitus will be enrolled in the trial.
Timeline
- Start
- 2017-11-30
- Primary completion
- 2018-12-30
- Completion
- 2019-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rE-4 | Unknown | 5 ug | Subcutaneous |
| Subject | rE-4 | Unknown | 10 ug | Subcutaneous |